+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glucosamine Market by Type, Form, Source, Distribution Channel, Application, End User - Global Forecast to 2030- Product Image
Glucosamine Market by Type, Form, Source, Distribution Channel, Application, End User - Global Forecast to 2030- Product Image
Sale

Glucosamine Market by Type, Form, Source, Distribution Channel, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887504
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The glucosamine market is experiencing important changes due to shifting consumer health priorities, increased focus on sustainable sourcing, and ongoing product innovation. Senior executives must navigate evolving expectations and an increasingly intricate regulatory landscape to secure lasting growth in this sector.

Market Snapshot: Glucosamine Market Overview

The Glucosamine Market grew from USD 964.36 million in 2024 to USD 1.01 billion in 2025. It is expected to continue growing at a CAGR of 5.30%, reaching USD 1.31 billion by 2030. This growth is attributed to the expanding demand for joint-health supplements, increasing use in animal nutrition, and new applications in skin care and cosmeceuticals. The market also reflects a dynamic blend of established players and innovative entrants, with regional trends playing a central role.

Scope & Segmentation

  • Product Types: Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride, N-Acetyl Glucosamine
  • Forms: Capsules & Tablets, Liquid, Powder
  • Sources: Animal-Derived, Plant-Based
  • Distribution Channels: Offline (Pharmaceutical Stores, Specialty Nutrition Stores), Online Platforms
  • Applications: Animal Nutrition, Dietary Supplements, Joint Health, Skin Care
  • End Users: Healthcare Institutions (Clinics, Hospitals), Individuals
  • Key Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, major EU markets, Gulf countries, and select African nations), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia)
  • Featured Companies: More than twenty global suppliers and manufacturers, encompassing ingredient producers, biotechnology specialists, and contract manufacturers across North America, Europe, and Asia.

Key Takeaways

  • The glucosamine market is widening beyond osteoarthritis relief to include animal feed improvements and advanced skin care formulations, reflecting deeper cross-industry demand.
  • Sourcing approaches are shifting: traditional animal-derived glucosamine is being replaced by plant-based and biofermentation options suitable for clean-label claims.
  • Digital health platforms are emerging as channels for personalized supplement regimens, enhancing consumer insights and engagement for brand owners.
  • Regulatory scrutiny is intensifying, particularly around ingredient traceability, labeling, and quality compliance, driving investment in blockchain-enabled supply chain transparency.
  • Regional differences are prominent: North America emphasizes clinical validation, while Asia-Pacific drives mass-market adoption and Europe advances harmonization of quality and safety standards.

Tariff Impact

Recent US tariff adjustments have raised raw material costs from major exporters, especially for chitosan and shellfish derivatives. This shift is encouraging manufacturers to reassess supplier networks and prioritize near-shoring or domestic production. While larger suppliers may absorb some increased costs, smaller firms are leveraging alternative sourcing to maintain pricing flexibility and disrupt incumbent positions.

Methodology & Data Sources

This report uses a blend of secondary research—scientific journals, regulatory filings, industry databases—and primary interviews with over twenty industry specialists and executives. Quantitative insights are triangulated with import-export data and corporate disclosures to ensure accuracy and reduce bias. Segment definitions are based on iterative expert consultations.

Why This Report Matters

  • Provides actionable insights into evolving product trends, regulatory demands, and competitive strategies within the glucosamine sector.
  • Enables targeted investment and go-to-market strategies by revealing region-specific opportunities, technology shifts, and channel dynamics.
  • Supports risk mitigation by detailing the impact of new tariffs, supply chain transitions, and advances in clinical validation approaches.

Conclusion

The glucosamine market is rapidly evolving. Senior decision-makers who adapt to new sourcing models, shifting health trends, and digital integration stand to secure long-term advantage. Informed strategy, grounded in rigorous research, is essential for sustained growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Glucosamine Market, by Type
8.1. Introduction
8.2. Glucosamine Hydrochloride
8.3. Glucosamine Sulfate Potassium Chloride
8.4. Glucosamine Sulfate Sodium Chloride
8.5. N-Acetyl Glucosamine
9. Glucosamine Market, by Form
9.1. Introduction
9.2. Capsules & Tablets
9.3. Liquid
9.4. Powder
10. Glucosamine Market, by Source
10.1. Introduction
10.2. Animal-Derived
10.3. Plant-Based
11. Glucosamine Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.2.1. Pharmaceutical Stores
11.2.2. Specialty Nutrition Stores
11.3. Online Platforms
12. Glucosamine Market, by Application
12.1. Introduction
12.2. Animal Nutrition
12.3. Dietary Supplements
12.4. Joint Health
12.5. Skin Care
13. Glucosamine Market, by End User
13.1. Introduction
13.2. Healthcare Institutions
13.2.1. Clinics
13.2.2. Hospitals
13.3. Individuals
14. Americas Glucosamine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Glucosamine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Glucosamine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Aden Healthcare LTD.
17.3.2. Andra Medi Pharma India Pvt. Ltd.
17.3.3. Bio-gen Extracts Pvt. Ltd.
17.3.4. Captek Softgel International Inc.
17.3.5. Cargill, Inc.
17.3.6. Cellmark AB
17.3.7. ENOMARK PHARMA PRIVATE LIMITED
17.3.8. Ethical Naturals Inc.
17.3.9. Fermentis Life Sciences Private Limited
17.3.10. Golden Shell Pharmaceutical Co. Ltd.
17.3.11. Kabir Lifesciences
17.3.12. Koyo Chemical Co., Ltd.
17.3.13. Lifecare Neuro Products Limited
17.3.14. Manus Aktteva Biopharma LLP
17.3.15. NutriScience Innovations, LLC
17.3.16. Panvo Organics Pvt Ltd.
17.3.17. Pax Healthcare Pvt Limited
17.3.18. Schiff Nutrition International Inc.
17.3.19. SMPNutra Inc.
17.3.20. Spectrum Chemical Manufacturing Corp.
17.3.21. TSI Group LTD
17.3.22. United Laboratories, Inc.
17.3.23. VELNEX MEDICARE INDIA PRIVATE LIMITED
17.3.24. Wellable Marine Biotech Holding Limited
17.3.25. Zhejiang AOXING Biotechnology Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. GLUCOSAMINE MARKET MULTI-CURRENCY
FIGURE 2. GLUCOSAMINE MARKET MULTI-LANGUAGE
FIGURE 3. GLUCOSAMINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL GLUCOSAMINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL GLUCOSAMINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GLUCOSAMINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE POTASSIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE SODIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY CAPSULES & TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GLUCOSAMINE MARKET SIZE, BY ANIMAL-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GLUCOSAMINE MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GLUCOSAMINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GLUCOSAMINE MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GLUCOSAMINE MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GLUCOSAMINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GLUCOSAMINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GLUCOSAMINE MARKET SIZE, BY INDIVIDUALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. CANADA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. CANADA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. CANADA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. CANADA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 58. CANADA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. CANADA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. CANADA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 63. MEXICO GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. MEXICO GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 102. GERMANY GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. GERMANY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 104. GERMANY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. GERMANY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. GERMANY GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 107. GERMANY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. GERMANY GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. GERMANY GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 110. FRANCE GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. FRANCE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 112. FRANCE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. FRANCE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. FRANCE GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 115. FRANCE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. FRANCE GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 126. ITALY GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. ITALY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 128. ITALY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. ITALY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ITALY GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 131. ITALY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ITALY GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. ITALY GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 134. SPAIN GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 136. SPAIN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. SPAIN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SPAIN GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 139. SPAIN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. SPAIN GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. SPAIN GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 166. DENMARK GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. DENMARK GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 168. DENMARK GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. DENMARK GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. DENMARK GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 171. DENMARK GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. DENMARK GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. DENMARK GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 182. QATAR GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. QATAR GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 184. QATAR GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. QATAR GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. QATAR GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 187. QATAR GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. QATAR GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. QATAR GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 190. FINLAND GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 192. FINLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. FINLAND GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 195. FINLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. FINLAND GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 214. EGYPT GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 216. EGYPT GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 217. EGYPT GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. EGYPT GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 219. EGYPT GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. EGYPT GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. EGYPT GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 224. TURKEY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. TURKEY GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 227. TURKEY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. TURKEY GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. TURKEY GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 238. NORWAY GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. NORWAY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 240. NORWAY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 241. NORWAY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. NORWAY GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. NORWAY GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. NORWAY GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 246. POLAND GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. POLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 248. POLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 249. POLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. POLAND GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 251. POLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. POLAND GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. POLAND GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 271. CHINA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 272. CHINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 273. CHINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 274. CHINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. CHINA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 276. CHINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. CHINA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. CHINA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 279. INDIA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 280. INDIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 281. INDIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 282. INDIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. INDIA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 284. INDIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. INDIA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. INDIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 287. JAPAN GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 289. JAPAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 290. JAPAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. JAPAN GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 292. JAPAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. JAPAN GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. JAPAN GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 319. THAILAND GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 320. THAILAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 321. THAILAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 322. THAILAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. THAILAND GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 324. THAILAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. THAILAND GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. THAILAND GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 358. VIETNAM GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 359. TAIWAN GLUCOSAMINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 360. TAIWAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 361. TAIWAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 362. TAIWAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 363. TAIWAN GLUCOSAMINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 364. TAIWAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 365. TAIWAN GLUCOSAMINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 366. TAIWAN GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 367. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 368. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Glucosamine market report include:
  • Aden Healthcare LTD.
  • Andra Medi Pharma India Pvt. Ltd.
  • Bio-gen Extracts Pvt. Ltd.
  • Captek Softgel International Inc.
  • Cargill, Inc.
  • Cellmark AB
  • ENOMARK PHARMA PRIVATE LIMITED
  • Ethical Naturals Inc.
  • Fermentis Life Sciences Private Limited
  • Golden Shell Pharmaceutical Co. Ltd.
  • Kabir Lifesciences
  • Koyo Chemical Co., Ltd.
  • Lifecare Neuro Products Limited
  • Manus Aktteva Biopharma LLP
  • NutriScience Innovations, LLC
  • Panvo Organics Pvt Ltd.
  • Pax Healthcare Pvt Limited
  • Schiff Nutrition International Inc.
  • SMPNutra Inc.
  • Spectrum Chemical Manufacturing Corp.
  • TSI Group LTD
  • United Laboratories, Inc.
  • VELNEX MEDICARE INDIA PRIVATE LIMITED
  • Wellable Marine Biotech Holding Limited
  • Zhejiang AOXING Biotechnology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.01 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.31 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Glucosamine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Glucosamine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 88 Pages
  • Global
From
Glucosamine - Global Strategic Business Report - Product Image

Glucosamine - Global Strategic Business Report

  • Report
  • 167 Pages
  • Global
From
2025 Glucosamine Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Glucosamine Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 147 Pages
  • Global
From
Glucosamine (CAS 3416-24-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Glucosamine (CAS 3416-24-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
D-Glucosamine Hydrochloride (CAS 66-84-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

D-Glucosamine Hydrochloride (CAS 66-84-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From

About the Glucosamine Market

Glucosamine is a naturally occurring compound found in the human body and is used in the treatment of immune disorders. It is used to reduce inflammation and pain associated with these disorders, as well as to improve joint mobility. Glucosamine is available in both oral and topical forms, and is often combined with other drugs to increase its effectiveness. It is also used in combination with other drugs to treat autoimmune diseases such as rheumatoid arthritis, lupus, and psoriasis. Glucosamine is a popular supplement for those suffering from immune disorders, as it is generally considered safe and effective. It is also widely available over the counter, making it an attractive option for those looking for an alternative to prescription medications. The glucosamine market is highly competitive, with many companies offering products that contain the compound. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Other companies that offer glucosamine products include Nature's Bounty, Schiff, and Solgar. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.